🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a single-center, prospective, open-label, randomized controll...
Status
Completed
Location
Fourth Hospital of Hebei Medical University
Start Date
2021-09-01
Trial ID
NCT05086627
Treatments Being Tested
For this study, unfavorable intermediate risk prostate cancer patients will...
Status
Recruiting
Location
NYU Langone Health
Start Date
2024-04-16
Trial ID
NCT06397703
Treatments Being Tested
This is a open-label, single-arm study to investigate the safety and effica...
Status
Suspended
Location
Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2019-11-01
Trial ID
NCT04558684
Treatments Being Tested
This study will test whether the combination of radiation and Dostarlimab i...
Status
Recruiting
Location
Memorial Sloan Kettering Basking Ridge (All Protocol Activites)
Start Date
2021-04-02
Trial ID
NCT04774419
Treatments Being Tested
The present study is proposed to compare a rapid fractionation schedule of ...
Status
Recruiting
Location
Tata Memorial Hospital
Start Date
2020-06-19
Trial ID
NCT03997110
Treatments Being Tested
The purpose of this study is to investigate the efficacy and safety of comb...
Status
Unknown
Location
West China Hospital, Sichuan University
Start Date
2022-09-01
Trial ID
NCT05763927
Treatments Being Tested
This study aims to evaluate safety and efficacy of nivolumab (anti-PD-1 ant...
Status
Completed
Location
Fukushima Medical University Hospital
Start Date
2018-03-28
Trial ID
NCT03453164
Treatments Being Tested
This is a multicenter, prospective, phase II study evaluating total neoadju...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-20
Trial ID
NCT07175636
Treatments Being Tested
To explore the efficacy and safety of radiotherapy followed by PD-1+ standa...
Status
Unknown
Location
Multiple Locations
Start Date
2023-05-01
Trial ID
NCT05640726
Treatments Being Tested
PRO-BOOST-LC is a prospective, multicenter, randomized phase II/III clinica...
Status
Recruiting
Location
Affidea Nu-Med, Center of Oncological Diagnostics and Therapy
Start Date
2026-03-19
Trial ID
NCT07426055